信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體
Polyclonal Antibody to Signal Transducer And Activator Of Transcription 3 (STAT3)
APRF; Acute-Phase Response Factor
- 編號PAB743Mi03
- 物種Homo sapiens (Human，人), Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Bos taurus; Bovine (Cattle，牛) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB743Mi03-信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
FITC staining on IF; Sample: Human Hela cell; Primary Ab: 20ug/ml Rabbit Anti-Multi-species STAT3 Antibody Second Ab: 2μg/ml FITC-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb18)
-
IHC圖
-
Western Blot; Sample: Rat Serum Primary Ab: 0.1μg/ml Rabbit Anti-Multi-species STAT3 Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Western Blot; Sample: Lane1: Human Serum; Lane2: Human Plasma; Lane3: Human Lung lysate; Lane4: Hela cell lysate; Lane5: Rat Cerebrum lysate
Primary Ab: 2μg/ml Rabbit Anti-Multi-species STAT3 Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Sample: Lane1: Mouse Lung lysate; Lane2: Mouse Cerebrum lysate; Lane3: Hela cell lysate
Primary Ab: 0.1μg/ml Rabbit Anti-Multi-species STAT3 Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對STAT3的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別STAT3。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人), Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Bos taurus; Bovine (Cattle，牛) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB743Mi01 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi02 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi03 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi04 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi05 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB743Mi03 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi01 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi02 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi04 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi05 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi27 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi22 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi23 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi24 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi21 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi25 | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB743Mi | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB743Mi | 信號傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Pharmaceutics | Oleacein and Foam Cell Formation in Human Monocyte-Derived Macrophages: A Potential Strategy Against Early and Advanced Atherosclerotic Lesions [Pubmed: 32283795] |
| CLINICAL IMMUNOLOGY | Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients [Pubmed: 32791312] |
留言咨詢
